Our results are also consistent with other reports showing that AKT inhibition by MK2206 reduced EZH2 protein stability in several cancer cells (Riquelme et al., 2016), indicating the methylation-phosphorylation switch of EZH2 exists in many cells, but T47D is defective in this pathway. The gene discussed is EZH2; the disease is cancer.